These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24599583)

  • 21. Clinical spectrum and survival analysis of 145 cases of HIV-negative Castleman's disease: renal function is an important prognostic factor.
    Zhang L; Li Z; Cao X; Feng J; Zhong D; Wang S; Zhou D; Li J
    Sci Rep; 2016 Mar; 6():23831. PubMed ID: 27029894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study.
    Guihot A; Couderc LJ; Agbalika F; Galicier L; Bossi P; Rivaud E; Scherrer A; Zucman D; Katlama C; Oksenhendler E
    Eur Respir J; 2005 Jul; 26(1):118-25. PubMed ID: 15994398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases.
    Kojima M; Nakamura N; Tsukamoto N; Yokohama A; Itoh H; Kobayashi S; Kashimura M; Masawa N; Nakamura S
    Lupus; 2011 Jan; 20(1):44-50. PubMed ID: 20965954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Castleman's disease: atypical manifestation in an 11-year-old girl.
    Gidvani VK; Tyree MM; Bhowmick SK
    South Med J; 2001 Feb; 94(2):250-3. PubMed ID: 11235046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management.
    Madan R; Chen JH; Trotman-Dickenson B; Jacobson F; Hunsaker A
    Eur J Radiol; 2012 Jan; 81(1):123-31. PubMed ID: 20643523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thoracoscopic approach to giant lymph node hyperplasia (Castleman's disease).
    Sica GS; Di Lorenzo N; Sileri PP; Gaspari AL
    Surg Laparosc Endosc Percutan Tech; 1999 Aug; 9(4):282-5. PubMed ID: 10871178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
    Tohda S; Murakami N; Nara N
    Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Castleman's disease mimetizing pancreatic tumor.
    Apodaca-Torrez FR; Filho BH; Beron RI; Goldenberg A; Goldman SM; Lobo EJ
    JOP; 2012 Jan; 13(1):94-7. PubMed ID: 22233957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry.
    Murray PG; Deacon E; Young LS; Barletta JM; Mann RB; Ambinder RF; Rowlands DC; Jones EL; Ramsay AD; Crocker J
    Hematol Pathol; 1995; 9(1):17-26. PubMed ID: 7628995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of multicentric angio-follicular lymph node hyperplasia (Castleman's disease).
    Batra Y; Choudhry A; Gupta SD
    Trop Gastroenterol; 1999; 20(4):180-1. PubMed ID: 10769608
    [No Abstract]   [Full Text] [Related]  

  • 31. Castleman's disease: three case reports and a review of the literature.
    Newlon JL; Couch M; Brennan J
    Ear Nose Throat J; 2007 Jul; 86(7):414-8. PubMed ID: 17702325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease.
    Peh SC; Shaminie J; Poppema S; Kim LH
    Singapore Med J; 2003 Apr; 44(4):185-91. PubMed ID: 12952030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unique presentation of Epstein-Barr virus-associated Castleman's disease.
    Gomes H; Huyett P; Laver N; Wein RO
    Am J Otolaryngol; 2013; 34(3):262-4. PubMed ID: 23394816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical features and prognosis in 49 patients with Castleman's disease].
    Yu GP; Wang SJ; Shi J; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):570-4. PubMed ID: 19968073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman's disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately.
    Lan X; Li Z; Zhang M
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1265-1277. PubMed ID: 29736622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors.
    Shin M; Male I; Beane TJ; Villefranc JA; Kok FO; Zhu LJ; Lawson ND
    Development; 2017 Feb; 144(3):531. PubMed ID: 28143848
    [No Abstract]   [Full Text] [Related]  

  • 37. Multicentric Castleman disease with TAFRO syndrome and Sjögren's.
    Li ZY; Kim S; Huang S; Mian R
    Clin Case Rep; 2019 Dec; 7(12):2388-2392. PubMed ID: 31893065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin/sodium hyaluronate binding on nano-hydroxyapatite coated titanium surface improves MC3T3-E1 osteogenesis.
    Liu C; Dong JY; Yue LL; Liu SH; Wan Y; Liu H; Tan WY; Guo QQ; Zhang D
    PLoS One; 2017; 12(2):e0171693. PubMed ID: 28182765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience.
    Seo S; Yoo C; Yoon DH; Kim S; Park JS; Park CS; Huh J; Suh C
    Blood Res; 2014 Dec; 49(4):253-8. PubMed ID: 25548759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman's disease.
    Liu C; Liu YR; Chen J; Zhuo SY; Dalin M; Liu SH; Wei FC
    Ann Hematol; 2014 Jul; 93(7):1177-83. PubMed ID: 24599583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.